Kathryn Sykes | Vice President Research And Product Development
Calviri Inc

Kathryn Sykes, Vice President Research And Product Development, Calviri Inc

Kathryn Sykes has decades of experience inventing and developing innovative molecular, genetic and biochemical technologies to manipulate the immune system towards better health. Before joining Calviri, she grew the labs at HealthTell and served as V.P. of Research. Previously, she was a professor in the School of Life Sciences at the Biodesign Institute at Arizona State University. At the University of Texas Southwestern Medical School, she pursued technologies that became the basis of a Texas biotechnology company, ultimately acquired by Macrogenics. Dr. Sykes received her B.S. in Biology and Economics from Duke University and her Ph.D. in Biochemistry and Genetics from Duke University Medical Center.

Appearances:



Day 2, September 29 @ 09:10

RNA frameshift errors provide new product opportunities against cancer

Day 3, September 30th @ 14:40

RNA frameshift errors provide new product opportunities against cancer

last published: 24/Sep/20 10:05 GMT
last published: 24/Sep/20 10:05 GMT
last published: 24/Sep/20 10:05 GMT
last published: 24/Sep/20 10:05 GMT
last published: 24/Sep/20 10:05 GMT
last published: 24/Sep/20 10:05 GMT
last published: 24/Sep/20 10:05 GMT
last published: 24/Sep/20 10:05 GMT
last published: 24/Sep/20 10:05 GMT
last published: 24/Sep/20 10:06 GMT

back to speakers